DENTSPLY SIRONA (XRAY) Research Coverage Started at Deutsche Bank

Deutsche Bank initiated coverage on shares of DENTSPLY SIRONA (NASDAQ:XRAY) in a report released on Friday morning, Marketbeat reports. The firm issued a buy rating and a $81.00 price objective on the medical instruments supplier’s stock.

Other analysts also recently issued research reports about the stock. HC Wainwright downgraded shares of DENTSPLY SIRONA from a buy rating to a neutral rating and set a $68.00 price objective for the company. in a research report on Thursday, November 30th. Stifel Nicolaus reaffirmed a buy rating on shares of DENTSPLY SIRONA in a report on Thursday, October 19th. Morgan Stanley lifted their target price on shares of DENTSPLY SIRONA from $66.00 to $67.00 and gave the company an overweight rating in a report on Thursday, August 10th. TheStreet raised shares of DENTSPLY SIRONA from a c rating to a b- rating in a report on Friday, November 3rd. Finally, Jefferies Group cut their target price on shares of DENTSPLY SIRONA from $72.00 to $66.00 and set a buy rating on the stock in a report on Wednesday, August 23rd. Two investment analysts have rated the stock with a sell rating, three have issued a hold rating and nine have issued a buy rating to the company. The stock has an average rating of Buy and an average target price of $68.83.

Shares of DENTSPLY SIRONA (NASDAQ:XRAY) opened at $64.90 on Friday. The firm has a market cap of $14,906.42, a P/E ratio of 25.86, a PEG ratio of 2.57 and a beta of 1.31. The company has a current ratio of 2.32, a quick ratio of 1.59 and a debt-to-equity ratio of 0.21. DENTSPLY SIRONA has a 12-month low of $52.53 and a 12-month high of $68.98.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings data on Friday, November 3rd. The medical instruments supplier reported $0.70 earnings per share for the quarter, topping the consensus estimate of $0.66 by $0.04. The business had revenue of $1.01 billion during the quarter, compared to the consensus estimate of $978.99 million. DENTSPLY SIRONA had a negative net margin of 20.33% and a positive return on equity of 7.56%. The company’s revenue was up 5.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.66 EPS. research analysts expect that DENTSPLY SIRONA will post 2.65 earnings per share for the current fiscal year.

In other DENTSPLY SIRONA news, CFO Nicholas W. Alexos acquired 50,000 shares of the firm’s stock in a transaction that occurred on Monday, November 13th. The shares were acquired at an average cost of $65.85 per share, for a total transaction of $3,292,500.00. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Francis J. Lunger sold 8,900 shares of the business’s stock in a transaction dated Monday, November 13th. The stock was sold at an average price of $65.90, for a total transaction of $586,510.00. The disclosure for this sale can be found here. Insiders own 1.99% of the company’s stock.

A number of large investors have recently added to or reduced their stakes in the business. Alps Advisors Inc. lifted its holdings in DENTSPLY SIRONA by 0.3% in the 2nd quarter. Alps Advisors Inc. now owns 7,523 shares of the medical instruments supplier’s stock valued at $488,000 after purchasing an additional 20 shares in the last quarter. Wetherby Asset Management Inc. lifted its holdings in DENTSPLY SIRONA by 0.6% in the 2nd quarter. Wetherby Asset Management Inc. now owns 5,004 shares of the medical instruments supplier’s stock valued at $324,000 after purchasing an additional 30 shares in the last quarter. BRYN MAWR TRUST Co lifted its holdings in DENTSPLY SIRONA by 0.5% in the 2nd quarter. BRYN MAWR TRUST Co now owns 12,064 shares of the medical instruments supplier’s stock valued at $782,000 after purchasing an additional 65 shares in the last quarter. Nordea Investment Management AB lifted its holdings in DENTSPLY SIRONA by 0.7% in the 2nd quarter. Nordea Investment Management AB now owns 10,235 shares of the medical instruments supplier’s stock valued at $664,000 after purchasing an additional 75 shares in the last quarter. Finally, Security National Bank of Sioux City Iowa IA lifted its holdings in DENTSPLY SIRONA by 0.4% in the 2nd quarter. Security National Bank of Sioux City Iowa IA now owns 23,081 shares of the medical instruments supplier’s stock valued at $1,497,000 after purchasing an additional 102 shares in the last quarter. Institutional investors own 96.58% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “DENTSPLY SIRONA (XRAY) Research Coverage Started at Deutsche Bank” was posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this news story on another domain, it was copied illegally and reposted in violation of US and international copyright legislation. The original version of this news story can be viewed at https://www.dispatchtribunal.com/2017/12/11/dentsply-sirona-xray-research-coverage-started-at-deutsche-bank.html.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Analyst Recommendations for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply